• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚氨酯功能化淀粉纳米晶作为抗结核药物载体。

Polyurethane-functionalized starch nanocrystals as anti-tuberculosis drug carrier.

机构信息

School of Chemical Sciences, Central University of Gujarat, Gandhinagar, 382030, India.

出版信息

Sci Rep. 2021 Apr 15;11(1):8331. doi: 10.1038/s41598-021-86767-1.

DOI:10.1038/s41598-021-86767-1
PMID:33859215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8050055/
Abstract

Studies related to loading ability and delivery of clinically used first-line anti-tuberculosis drugs (ATDs) such as isoniazid, rifampicin, pyrazinamide and streptomycin on the surface of starch-derived bulk and nanopolyurethanes (SBPUs and SNPUs) as drug delivery systems (DDS) have been focused to minimise or remove the drug-associated adverse effects. The efficiencies of nanopolyurethanes obtained from the differently substituted cyclic aliphatic and aromatic isocyanates have been studied for drug loading and release purposes. Different advanced instrumental techniques analysed the structural and morphological properties, thermal stability and crystallinity of the starch nanopolyurethans. Average particle sizes ranging from 27.35-42.38 nm to 126.89-218.60 nm for starch nanopolyurethans, SNPU3i and SNPU4i, respectively, were determined by high-resolution transmission electron microscopy. Similarly, the loading efficiency of ATDs to the surfaces of SNPUs and SBPUs was observed in the range of 60-97% while ATDs-loaded SNPUs showed a sustainable release profile for all ATDs except for streptomycin. However, most SBPUs provided burst-release for all the above-mentioned ATDs in pH-dependent studies. The anti-tuberculosis assay against the Mycobacterium tuberculosis H37Rv strain revealed that streptomycin-loaded SNPU4i and isoniazid-loaded SNPU7i are approximately 42 and 7 times more active than the native streptomycin and isoniazid, respectively.

摘要

已将重点放在研究将异烟肼、利福平、吡嗪酰胺和链霉素等临床一线抗结核药物(ATDs)的负载能力和输送能力与淀粉衍生的块状和纳米聚氨基甲酸酯(SBPUs 和 SNPUs)作为药物输送系统(DDS)结合起来,以尽量减少或消除与药物相关的不良反应。为了药物负载和释放的目的,已经研究了不同取代的环状脂肪族和芳香族异氰酸酯制得的纳米聚氨基甲酸酯的效率。不同的先进仪器技术分析了淀粉纳米聚氨基甲酸酯的结构和形态特性、热稳定性和结晶度。通过高分辨率透射电子显微镜确定淀粉纳米聚氨基甲酸酯 SNPU3i 和 SNPU4i 的平均粒径分别为 27.35-42.38nm 和 126.89-218.60nm。同样,观察到 ATDs 对 SNPUs 和 SBPUs 表面的负载效率在 60-97%之间,而 ATDs 负载的 SNPUs 除了链霉素外,所有 ATDs 都显示出可持续的释放特性。然而,在 pH 依赖性研究中,大多数 SBPUs 为所有上述 ATDs 提供了突释释放。针对结核分枝杆菌 H37Rv 株的抗结核测定表明,负载链霉素的 SNPU4i 和负载异烟肼的 SNPU7i 的活性分别比天然链霉素和异烟肼高约 42 倍和 7 倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/ae208addd4c7/41598_2021_86767_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/2648838a48c1/41598_2021_86767_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/43896a9aebb5/41598_2021_86767_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/24cc44c78980/41598_2021_86767_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/c24f6c080e70/41598_2021_86767_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/16d5367af488/41598_2021_86767_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/5e09edd4b286/41598_2021_86767_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/829d425a1a3a/41598_2021_86767_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/a2dba7b1136d/41598_2021_86767_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/2a72cd21bc00/41598_2021_86767_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/11f830eb7ea9/41598_2021_86767_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/ae208addd4c7/41598_2021_86767_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/2648838a48c1/41598_2021_86767_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/43896a9aebb5/41598_2021_86767_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/24cc44c78980/41598_2021_86767_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/c24f6c080e70/41598_2021_86767_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/16d5367af488/41598_2021_86767_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/5e09edd4b286/41598_2021_86767_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/829d425a1a3a/41598_2021_86767_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/a2dba7b1136d/41598_2021_86767_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/2a72cd21bc00/41598_2021_86767_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/11f830eb7ea9/41598_2021_86767_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68eb/8050055/ae208addd4c7/41598_2021_86767_Fig9_HTML.jpg

相似文献

1
Polyurethane-functionalized starch nanocrystals as anti-tuberculosis drug carrier.聚氨酯功能化淀粉纳米晶作为抗结核药物载体。
Sci Rep. 2021 Apr 15;11(1):8331. doi: 10.1038/s41598-021-86767-1.
2
First-line anti-tubercutilosis drugs-loaded starch nanocrystals for combating the threat of M. tuberculosis H37Rv strain.载一线抗结核药物的淀粉纳米晶用于抗击 H37Rv 结核分枝杆菌菌株的威胁。
Carbohydr Res. 2020 Sep;495:108070. doi: 10.1016/j.carres.2020.108070. Epub 2020 Jun 27.
3
Streptomycin sulphate loaded solid lipid nanoparticles show enhanced uptake in macrophage, lower MIC in Mycobacterium and improved oral bioavailability.硫酸链霉素负载固体脂质纳米粒在巨噬细胞中表现出增强的摄取,在分枝杆菌中降低 MIC,并提高口服生物利用度。
Eur J Pharm Biopharm. 2021 Mar;160:100-124. doi: 10.1016/j.ejpb.2021.01.009. Epub 2021 Jan 23.
4
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.用于实验性结核病的基于聚(DL-丙交酯-共-乙交酯)纳米颗粒的可吸入持续给药系统
J Antimicrob Chemother. 2003 Dec;52(6):981-6. doi: 10.1093/jac/dkg477. Epub 2003 Nov 12.
5
Pulmonary Delivery of Isoniazid in Nanogel-Loaded Chitosan Hybrid Microparticles for Inhalation.载药纳米凝胶-壳聚糖复合微球肺部递药用于吸入给药
J Aerosol Med Pulm Drug Deliv. 2019 Apr;32(2):78-87. doi: 10.1089/jamp.2018.1460. Epub 2018 Dec 8.
6
Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles.通过功能化介孔硅纳米粒子将抗结核药物靶向递送至感染分枝杆菌的巨噬细胞内。
Antimicrob Agents Chemother. 2012 May;56(5):2535-45. doi: 10.1128/AAC.06049-11. Epub 2012 Feb 21.
7
High isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.来自巴基斯坦的利福平敏感结核分枝杆菌肺部分离株中异烟肼耐药率较高。
PLoS One. 2012;7(11):e50551. doi: 10.1371/journal.pone.0050551. Epub 2012 Nov 30.
8
[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].含吡嗪酰胺的6个月方案治疗初治肺结核患者的疗效及问题
Kekkaku. 2001 Jan;76(1):33-43.
9
Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.印度古吉拉特邦的原发性耐结核病及获得性利福平耐药情况。
Tubercle. 1988 Mar;69(1):37-42. doi: 10.1016/0041-3879(88)90038-4.
10
Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.喷雾干燥颗粒作为抗结核药物的肺部给药系统:设计、优化、体外和体内评价
Pharm Dev Technol. 2016 Dec;21(8):951-960. doi: 10.3109/10837450.2015.1081613. Epub 2015 Aug 31.

引用本文的文献

1
The Use of Particulate Systems for Tuberculosis Prophylaxis and Treatment: Opportunities and Challenges.颗粒系统在结核病预防和治疗中的应用:机遇与挑战
Microorganisms. 2023 Aug 2;11(8):1988. doi: 10.3390/microorganisms11081988.
2
Research progress of natural silk fibroin and the application for drug delivery in chemotherapies.天然丝素蛋白的研究进展及其在化疗药物递送中的应用
Front Pharmacol. 2023 Jan 4;13:1071868. doi: 10.3389/fphar.2022.1071868. eCollection 2022.

本文引用的文献

1
(Oligo)mannose functionalized hydroxyethyl starch nanocapsules: en route to drug delivery systems with targeting properties.(寡聚)甘露糖功能化羟乙基淀粉纳米胶囊:迈向具有靶向特性的药物递送系统之路。
J Mater Chem B. 2013 Sep 14;1(34):4338-4348. doi: 10.1039/c3tb20138d. Epub 2013 Jul 18.
2
Insights of synthetic analogues of anti-leprosy agents.抗麻风病药物的合成类似物的研究进展。
Bioorg Med Chem. 2019 Jul 1;27(13):2689-2717. doi: 10.1016/j.bmc.2019.04.032. Epub 2019 May 2.
3
The pathogenesis of post-primary tuberculosis. A game changer for vaccine development.
原发性肺结核的发病机制。疫苗研发的变革者。
Tuberculosis (Edinb). 2019 May;116S:S114-S117. doi: 10.1016/j.tube.2019.04.018. Epub 2019 Apr 26.
4
A role for ultrasound in the fabrication of carbohydrate-supported nanomaterials.超声在碳水化合物负载型纳米材料制备中的作用。
J Ultrasound. 2019 Jun;22(2):131-156. doi: 10.1007/s40477-019-00363-8. Epub 2019 Feb 27.
5
Polyurethane Nanoparticle-Loaded Fenofibrate Exerts Inhibitory Effects on Nonalcoholic Fatty Liver Disease in Mice.载有聚氨酯纳米颗粒的非诺贝特对小鼠非酒精性脂肪肝发挥抑制作用。
Mol Pharm. 2018 Oct 1;15(10):4550-4557. doi: 10.1021/acs.molpharmaceut.8b00548. Epub 2018 Sep 19.
6
Antibacterial and anti-TB tat-peptidomimetics with improved efficacy and half-life.具有增强疗效和半衰期的抗菌和抗结核 Tat 肽模拟物。
Eur J Med Chem. 2018 May 25;152:358-369. doi: 10.1016/j.ejmech.2018.04.039. Epub 2018 Apr 30.
7
A review on carbohydrate embedded polyurethanes: An emerging area in the scope of biomedical applications.碳水化合物嵌入型聚氨酯的综述:生物医学应用领域的一个新兴领域。
Carbohydr Polym. 2018 Feb 1;181:1003-1016. doi: 10.1016/j.carbpol.2017.11.049. Epub 2017 Nov 16.
8
Tuberculosis: a disease without boundaries.结核病:一种无国界的疾病。
Tuberculosis (Edinb). 2015 Sep;95(5):527-31. doi: 10.1016/j.tube.2015.05.017. Epub 2015 Jun 25.
9
Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis.当前用于有效递送生物活性药物分子以克服耐药性结核病的纳米技术方法。
Curr Pharm Des. 2015;21(22):3076-89. doi: 10.2174/1381612821666150531163254.
10
Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.脑肿瘤治疗中生物活性药物分子靶向递送的当前策略。
J Drug Target. 2015 Dec;23(10):865-87. doi: 10.3109/1061186X.2015.1029930. Epub 2015 Apr 2.